|
시장보고서
상품코드
2008134
메토프롤롤 주석산염 시장 : 투여 경로별, 용도별, 유통 채널별, 지역별Metoprolol Tartrate Market, By Route Of Administration, By Application, By Distribution Channel, By Geography |
||||||
메토프롤롤 주석산염 시장은 2026년에 25억 달러로 추정되고 있으며, 2033년까지 40억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.7%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 25억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 8.70% | 예측 금액(2033년) | 40억 달러 |
메토프롤롤 주석산염은 심박수를 낮추고 심장이 체내로 혈액을 보내는 효율을 높이는 작용을 하는 심혈관 질환 및 고혈압 치료를 목적으로 하는 선택적 베타1 수용체 차단제입니다. 고혈압, 심장으로의 혈류 부족으로 인한 흉통, 부정맥 치료에 사용됩니다. 메토프롤롤 주석산염은 주로 협심증, 심장 부정맥, 갑상선 기능 항진증 치료에 사용됩니다. 메토프롤롤 주석산염은 경구제와 주사제의 두 가지 제형이 있습니다. 메토프롤롤 주석산염의 제네릭 의약품은 로프레서(Lopressor)입니다. 메토프롤롤은 체내에서 분해되어 약물을 방출하도록 설계된 속방성 정제와 서방형 정제가 있으며, 모두 처방전이 필요한 의약품입니다.
시장 역학
전 세계에서 심혈관 질환의 유병률 증가는 예측 기간 중 글로벌 메토프롤롤 주석산염 시장을 촉진할 것으로 예상됩니다. 예를 들어 2021년 8월에 발표된 유럽 통계에 따르면 2019년 독일에서 약 4만 5,400건의 우회수술이 이루어졌다고 합니다. 또한 2016년 유럽 지역에서는 심혈관 질환으로 인해 168만 명이 사망했습니다. 심혈관 질환의 유병률에 관한 이 데이터에 따르면 25세에서 34세 사이의 연령대에서 고혈압이 증가하고 있으며, 유럽에서 이 연령대 인구의 약 3.4%가 고혈압을 앓고 있는 것으로 보고되었습니다. 또한 고혈압 환자의 54.6% 이상이 75세 이상이며, 이는 향후 수년간 메토프롤롤 주석산염의 수요를 견인할 것으로 예상됩니다.
이 보고서의 주요 특징
- 세계의 메토프롤롤 주석산염(Metoprolol Tartrate) 시장에 대해 조사 분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계의 메토프롤롤 주석산염 시장의 주요 기업 개요을 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계의 메토프롤롤 주석산염 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 메토프롤롤 주석산염 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 메토프롤롤 주석산염 시장 : 투여 경로별(2026-2033년)
제5장 세계의 메토프롤롤 주석산염 시장 : 용도별(2026-2033년)
제6장 세계의 메토프롤롤 주석산염 시장 : 유통 채널별(2026-2033년)
제7장 세계의 메토프롤롤 주석산염 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 섹션
KSA 26.04.30Metoprolol Tartrate Market is estimated to be valued at USD 2.5 Bn in 2026 and is expected to reach USD 4.0 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.5 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.70% | 2033 Value Projection: | USD 4.0 Bn |
Metoprolol Tartrate is a selective B1 receptor blocker medication that is designed for the treatment of cardiovascular diseases and hypertension, as it works as slowing down the heart rate and makes the heart more efficient at pumping blood around the body. It is used for treating high blood pressure issues, chest pain due to low blood circulation to the heart, and abnormal heart rate. Metoprolol Tartrate is mostly used in the treatment of Angina pectoris, Cardiac arrhythmias, and thyrotoxicosis. Metoprolol Tartrate is available in two types of formulations including oral and injectable. The generic form of Metoprolol Tartrate is Lopressor. Metoprolol comes in form of immediate-release tablets which are designed to disintegrate and release medicine and extended-release tablets and it is prescribed medicine only.
Market Dynamics
Increasing prevalence of cardiovascular diseases in various region is expected to drive the global metoprolol tartrate market over the forecast period. For instance, in August 2021, European statistics published data on cardiovascular diseases, stating that in the year 2019, approximately 45,400 bypass surgeries were conducted in Germany. Moreover, in the year 2016, 1.68 million deaths occurred due to cardiovascular diseases in the Europe region. The same data on prevalence of cardiovascular diseases reported that high blood pressure increased in age group from 25 to 34 years and that around 3.4% of the population between this age group in Europe was reported to have hypertensive diseases. Furthermore, more than 54.6% population of hypertension diseases were aged 75 years or older, which is expected to drive demand for metoprolol tartrate in upcoming years.
Key features of the study
- This report provides an in-depth analysis of the global metoprolol tartrate market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global metoprolol tartrate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Novartis Pharmaceuticals Canada Inc., AstraZeneca Pharma India Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Inc., CTX Life Sciences Pvt. Ltd., Hikma Pharmaceuticals PLC, Validus Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Aurobindo Pharma USA, Sandoz Canada Inc., Apotex Inc., Ipca Laboratories Ltd, and Rubicon Research Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global metoprolol tartrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global metoprolol tartrate market.
Market Segmentation
- By Route of administration
- Oral
- Injectable
- By Application
- Hypertension
- Cardiovascular
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Novartis Pharmaceuticals Canada Inc.
- AstraZeneca Pharma India Limited
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Inc.
- CTX Life Sciences Pvt. Ltd.
- Hikma Pharmaceuticals PLC
- Validus Pharmaceuticals LLC
- Alembic Pharmaceuticals Limited
- Aurobindo Pharma USA
- Sandoz Canada Inc.
- Apotex Inc.
- Ipca Laboratories Ltd
- Rubicon Research Pvt. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Metoprolol Tartrate Market, By Route of Administration, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
5. Global Metoprolol Tartrate Market, By Application, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
6. Global Metoprolol Tartrate Market, By Distribution Channel, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
7. Global Metoprolol Tartrate Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Novartis Pharmaceuticals Canada Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AstraZeneca Pharma India Limited
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sun Pharmaceutical Industries Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- CTX Life Sciences Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Validus Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Alembic Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Aurobindo Pharma USA
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sandoz Canada Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Ipca Laboratories Ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Rubicon Research Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
